Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma (Q73701966)
Jump to navigation
Jump to search
scientific article published on 01 August 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma |
scientific article published on 01 August 2003 |
Statements
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma (English)
Isaac Ben-Bassat
Izhar Hardan
Arnon Nagler
Avichai Shimoni
Abraham Avigdor
Moshe Yeshurun